Hemifacial Spasm Clinical Trial
Official title:
Observation of the Abnormal Potential From the Offending Vessel to the Facial Muscles of Hemifacial Spasm Patients
The pathophysiologic basis of hemifacial spasm is cross-transmission between different branches of the facial nerve. The hypothesis is that the cross-transmission is mediated by the sympathetic nerve fibers on the surface of the offending artery. The abnormal potential from the offending vessel to the facial muscles will be detected on hemifacial spasm patients, so as to determine if the sympathetic nerve fibers take part in the circuit of cross-transmission.
It's hypothesized that at the location where the facial nerve is compressed by an artery, ephaptic cross-transmission takes place between the nude facial nerve fibers and the sympathetic nerve fibers on the arterial surface. Thus action potentials could spread indirectly from one facial nerve fiber to several other facial nerve fibers (via the "bridge" of sympathetic fibers), or directly from the sympathetic fibers to facial nerve fibers. The investigators assume this is the electrophysiological basis of hemifacial spasm and its characteristic sign abnormal muscle response (AMR). If an abnormal potential from the offending artery to the facial muscles similar to AMR can be recorded, the hypothesis will be verified. ;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04474977 -
Microvascular Decompressive Surgery for Hemifacial Spasm
|
||
Withdrawn |
NCT01932255 -
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
|
N/A | |
Completed |
NCT00210431 -
Post Marketing Surveillance Study of Dysport
|
||
Recruiting |
NCT03306940 -
Botulinum Toxin A in the Treatment of Hemifacial Spasm
|
N/A | |
Completed |
NCT05103202 -
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
|
||
Unknown status |
NCT01726725 -
Hemifacial Spasm and Desflurane
|
N/A | |
Completed |
NCT01598961 -
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
|
N/A | |
Not yet recruiting |
NCT04589364 -
Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
|
Phase 3 | |
Completed |
NCT01613781 -
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
|
N/A | |
Not yet recruiting |
NCT06195241 -
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm
|
Phase 4 | |
Completed |
NCT03508882 -
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
|
Phase 4 | |
Recruiting |
NCT04645277 -
Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm
|
||
Completed |
NCT03390803 -
Effect of Hemifacial Spasm on Intraocular Pressure Measurement
|
N/A | |
Completed |
NCT01728428 -
A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients
|
N/A | |
Completed |
NCT04621578 -
Transcutaneous Electrical Acupoint Stimulation on Postoperative Dizziness in Hemifacial Spasm Patients
|
N/A | |
Completed |
NCT00276315 -
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
|
Phase 3 | |
Completed |
NCT02761096 -
Effect of Acupuncture on Inflammation and Immune Function After Craniotomy
|
N/A | |
Unknown status |
NCT01564979 -
Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm
|
Phase 2 | |
Not yet recruiting |
NCT01546805 -
Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
|
N/A | |
Completed |
NCT01168388 -
Movement Disorder Survey in East China
|
N/A |